On May 30, 2019 Evelo Biosciences, Inc. (Nasdaq: EVLO) ("Evelo"), a clinical stage biotechnology company developing oral biologics that act on cells in the small intestine with striking therapeutic effects throughout the body, reported that management will present a corporate overview at two investor conferences in June (Press release, Evelo Biosciences, MAY 30, 2019, View Source [SID1234538812]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Healthcare Conference
Date:Thursday, June 6, 2019
Time:4:00 p.m. ET
Location: New York, NY

BMO Prescriptions for Success Healthcare Conference
Date:Tuesday, June 25, 2019
Time:2:40 p.m. ET
Location: New York, NY

A live audio webcast of both presentations will be available on the Investors section of the Evelo website at View Source Replays of the webcasts will be available for approximately 30 days following each presentation.